InspireMD financials
$0.6937+0.62%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.8M | $3.4M | $3.1M | $2.5M | $1.8M | $1.5M | $1.9M | $1.8M | $1.7M | $1.5M | $1.8M | $1.6M |
| Gross profit | -$774.0K | $687.0K | $1.2M | $864.0K | $313.0K | $292.0K | $469.0K | $414.0K | $331.0K | $292.0K | $505.0K | $438.0K |
| Gross margin | −43.7% | 20.2% | 37.5% | 34.2% | 17.6% | 19.1% | 24.1% | 22.9% | 19.0% | 19.3% | 28.7% | 28.1% |
| Operating income | -$14.4M | -$14.0M | -$12.1M | -$13.1M | -$13.0M | -$11.5M | -$9.4M | -$8.5M | -$8.3M | -$7.4M | -$5.8M | -$5.6M |
| Net income | -$14.3M | -$13.7M | -$11.8M | -$12.7M | -$13.2M | -$11.2M | -$9.2M | -$7.9M | -$7.9M | -$7.0M | -$5.4M | -$5.2M |
| Net margin | −808.8% | −402.9% | −373.5% | −503.7% | −739.7% | −730.3% | −470.7% | −435.9% | −454.8% | −465.4% | −306.9% | −332.8% |
| Diluted EPS | $-0.17 | $-0.16 | $-0.14 | $-0.17 | $-0.26 | $-0.22 | $-0.19 | $-0.16 | $-0.22 | $-0.21 | $-0.16 | $-0.15 |
| EBITDA | -$14.3M | -$13.8M | -$11.9M | -$12.9M | -$12.9M | -$11.4M | -$9.3M | -$8.4M | -$8.2M | -$7.3M | -$5.7M | -$5.6M |
| Operating cash flow | -$10.9M | -$12.3M | -$9.3M | -$8.6M | -$8.3M | -$8.8M | -$6.8M | -$5.7M | -$4.4M | -$5.1M | -$4.2M | -$4.0M |
| Free cash flow | -$11.2M | -$12.5M | -$9.7M | -$9.0M | -$8.9M | -$9.2M | -$7.1M | -$6.1M | -$4.8M | -$5.3M | -$4.4M | -$4.1M |
| Diluted shares | 84.7M | 83.8M | 82.8M | 73.5M | 51.0M | 50.0M | 49.2M | 48.4M | 35.9M | 34.2M | 33.9M | 34.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $15.1M | $11.4M | $8.9M | $63.4M | $11.5M | $12.4M |
| Short-term investments | $15.3M | $30.2M | $45.3M | $0.00 | $7.9M | $13.7M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $44.6M | $56.5M | $69.4M | $78.5M | $33.3M | $38.7M |
| Total liabilities | $13.1M | $12.9M | $14.2M | $14.4M | $13.1M | $10.3M |
| Shareholders' equity | $31.5M | $43.6M | $55.2M | $64.1M | $20.2M | $28.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology